You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Long-Acting G-CSF Analog for Treating ARS
SBC: BOLDER BIOTECHNOLOGY INC Topic: NIAIDDESCRIPTION provided by applicant Development of radiological nuclear medical countermeasures to treat Acute Radiation Syndrome ARS is a high priority research area for NIAID Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure often resulting i death Granulocyte colony stimulating ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Automated 3D quantitative analysis of dendritic spines imaged with light microsco
SBC: MICROBRIGHTFIELD, LLC Topic: NIMHDESCRIPTION provided by applicant In this Lab to Marketplace proposal we aim to develop the MBF SpineStudio software incorporating the innovative laboratory based NeuronStudio software created at the Mount Sinai School of Medicine Our SpineStudio software will enable automated detection reconstruction and morphological classification of the structural analysis of dendritic spines By creating this ...
SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
Delivering a Solar Flare Forecast Model that Improves Flare Forecast (Timing and Magnitude) Accuracy by 25%
SBC: NORTHWEST RESEARCH ASSOCIATES, INC. Topic: 943WMany activities and technological systems prevalent in today’s society – air traffic control and air travel, the power grids, communications, deep-water drilling operations, human spaceflight – are vulnerable to the effects of sudden flares from our Sun. Because the propagation speed for flare emission is the speed of light, it is necessary to forecast these events in order to mitigate thei ...
SBIR Phase I 2013 Department of CommerceNational Oceanic and Atmospheric Administration -
Novel Vector Survaillance Trap for Flying Insects
SBC: TDA RESEARCH, INC. Topic: DHP12007Civilian and military organizations throughout the world perform surveillance to combat vector-borne disease. Of particular concern to the U.S. military are mosquito genera Anopheles, Aedes and Culex, which are important vectors for malaria, dengue and West Nile virus respectively, and sand fly genera Phlebotomus and Lutzomyia, both vectors for leishmaniasis. The trap most commonly used for by U.S ...
SBIR Phase I 2013 Department of DefenseDefense Health Agency -
Flowing Water Optical Power Meter for Laser Measurements
SBC: High Precision Devices, Inc. Topic: N/AHigh Precision Devices, Inc. (HPD) proposes to use the Phase I SBIR as a vehicle to develop and market a commercially viable 25kW flowing water optical power meter (FWOPM) for industrial, research, and government applications. Building upon existing and fundamentally sound NIST design, and without sacrificing quality or accuracy, HPD will reduce costs and increase manufacturability using best prac ...
SBIR Phase I 2013 Department of CommerceNational Institute of Standards and Technology -
Biomarker discovery for immunodiagnosis of invasive candidiasis
SBC: DXDISCOVERY INC Topic: NIAIDDESCRIPTION (provided by applicant): Invasive candidiasis (IC) is one of the most serious threats to patients in a critical setting. With as many as 60,000 cases per year in the U.S., the total cost associated with IC in the U.S. may be as high as 2-4 billion/year. One of the most critical factors influencing patient outcome is early diagnosis. The goal of this project is a rapi and inexpensive i ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Elucidation of Antisickling Molecules in a Botanical with Antisickling Activity
SBC: INVENUX, LLC Topic: NCCAMDESCRIPTION: New therapeutic agents are urgently needed for the treatment of sickle cell disease (SCD), the world's most common genetic disease. Our long-term goal is to develop a drug for use in children that prevents the inexorable progression of SCD. SCD affects approximately 100,000 people in the United States and millions worldwide. It kills more children in Africa than HIV, but while HI ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
The anti-tumorigenic and anti-metastatic potential of Eya phosphatase inhibitors
SBC: SIXONE SOLUTIONS, LLC Topic: NCIDESCRIPTION (provided by applicant): Breast cancer is expected to cause 39,510 deaths of American women in 2012 and 450,000 deaths globally. Once breast cancer has spread, it is essentially incurable. A critical barrier to treating advanced breast cancer is the lack of cancer-specific drugs that are effective in a large percentage of cancer patients and have low toxicity. Sixone Solutions, LLC pro ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Remote focusing through spatial light modulation for multifocal multiphoton micro
SBC: BOULDER NONLINEAR SYSTEMS, INC. Topic: NIMHDESCRIPTION (provided by applicant): Nonlinear optical microscopy techniques (such as two-photon florescence) are being used to acquire volumetric (i.e. three dimensional) images that probe several hundred microns into scattering tissue. These techniques are being combined with fast acquisition schemes to allow imaging of live, moving specimens at high NA. This combination allows for high-resoluti ...
STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Novel Vitamin B6 based prodrugs of gemcitabine
SBC: MBC Pharma, Inc. Topic: NCIDESCRIPTION (provided by applicant): The long-term goal of this proposal is to develop more effective therapies for cancer, specifically pancreatic cancer. The specific focus of this proposal is to improve upon the anti-cancer activity of the drug gemcytabine. This will be accomplished by synthesizing novel conjugates of gemcytabine in a form that enables increased pathways for uptake into cancer ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health